Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael Rhodes

Premium

Michael Rhodes has left Life Technologies to join NanoString Technologies. At NanoString, Rhodes will be the director of collaboration and applications development and focus on digital gene expression technologies.

Rhodes held various positions at Life Tech, including most recently senior manager of the sequencing portfolio. He joined Applied Biosystems in 1999 in the genetic analysis division before the company merged with Invitrogen and became Life Tech.

In his new position, Rhodes will report to Joe Beechem, who also recently came to NanoString from Life Tech, where he was most recently vice president, head of advanced sequencing and head of global sequencing chemistry, biochemistry, and biophysics.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.